Nostrum Labs Agrees to Pay Up to $50 Million Over Underpayment of Medicaid Rebates

October 31, 2023 |

Nostrum Laboratories and its CEO have struck a potential $50 million settlement with the Department of Justice (DOJ) to resolve allegations the company knowingly underpaid Medicaid rebates for its Nitrofurantoin Oral Suspension (Nitro OS) generic product.
Source: Drug Industry Daily